Skip to main content

Net zero direction

A long term direction that must be grounded in a verified baseline

NEUVIOR’s net zero direction is strategic intent. A formal commitment, pathway or target date should be published only when scope, baseline, method and governance are evidenced.

Review the planning frameworkRead the evidence boundary
Current status | Strategic directionTarget date | Not asserted without evidenceReporting | Baseline and governance first

Commitment standard

Direction, commitment and delivery are different states.

A direction expresses intent. A commitment adds an accountable target and plan. Delivery requires measured progress against a stable boundary.

The website must keep these states visibly distinct.

Human decision requiredProceed only inside an evidenced and governed scope.
01

Direction

A long term environmental ambition that guides planning.

Current
02

Commitment

A defined target, boundary, method and accountable owner.

Requires evidence
03

Delivery

Measured progress supported by records for the reporting period.

Future evidence

Evidence pathway

Move from organisational boundary to reviewable progress.

A credible pathway should explain which operations are included, how emissions are measured, which reductions are prioritised and how residual claims are handled.

01

Scope

Define the entity, activities and value chain boundary.

02

Baseline

Establish a complete period and documented calculation method.

03

Plan

Prioritise direct reductions with owners and review points.

04

Report

Publish progress, limitations and material changes in method.

Integrity boundary

Do not make environmental ambition carry evidence it does not have.

Research funding, efficient software design or a supplier intention does not by itself prove a net zero pathway or carbon result.

01

No invented baseline

Do not backdate performance to periods before reliable company records exist.

02

No borrowed outcome

Do not treat a research project’s objective as NEUVIOR’s achieved reduction.

03

No generic badge

Do not imply external verification without the exact supporting record.

Make the next step useful

Bring the problem that needs a clearer decision.

Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.

Review the planning frameworkSpeak with NEUVIOR

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01What is NEUVIOR?

NEUVIOR is a pharmaceutical company registered in Scotland. It is building capabilities across medicines intelligence, governed technology and longer term development. PHARMORIS is its immediate product priority.

02What does NEUVIOR build today?

NEUVIOR is developing PHARMORIS, a human-governed medicines operations system in controlled, non-production development. It is intended to connect evidence, decisions, accountable work and value review. No independent TRL, deployment, customer adoption or clinical validation is claimed.

03What is PHARMORIS by NEUVIOR?

PHARMORIS is a configurable medicines operations system under controlled development. It is designed to help authorised teams progress medicine opportunities from evidence linked to its source, through an owned ActionCase, a human decision, delivery and review.

04Who founded NEUVIOR?

Varun Sharma is the Founder, CEO and CTO of NEUVIOR and leads the company and PHARMORIS product architecture.

05Where does NEUVIOR have a presence?

NEUVIOR works across Glasgow, London and Mumbai. Glasgow is the company origin and registered Scottish base. London supports commercial activity led by the founder. Mumbai supports market engagement in India and relationships across the pharmaceutical sector. These are different forms of presence. They do not imply three registered offices or regulated facilities.